Miromatrix Medical

Miromatrix uses perfusion decellularization to create transplantable organ scaffolds, with programs in kidney and liver. Strengths include whole-organ architecture preservation. Versus Trestle Biotherapeutics, Miromatrix focuses on recellularized donor scaffolds rather than stem cell-derived de novo tissues, creating different supply chain and immunogenicity considerations.